Wolters Kluwer acquires NurseTim
09 Gennaio 2023 - 04:20PM
Enhances portfolio of nursing education
Alphen aan den
2023 — Wolters Kluwer Health
today announced it has signed and completed an agreement to acquire
NurseTim, a US-based provider of nursing education solutions.
NurseTim will become part of Wolters Kluwer’s Health Learning,
Research & Practice (HLRP) business, which includes nursing
education and practice solutions that help ensure students are
ready for practice and nurses are prepared to deliver better
patient care and outcomes.
NurseTim’s NurseThink provides a set of test preparation tools
for faculty and students to prepare candidates for the Next
Generation National Council Licensure Examination (NCLEX) in the
U.S. In addition, the company provides hands-on nurse faculty
training through conferences and webinars.
“Combining our nursing education portfolio and NurseTim will
create a comprehensive suite of solutions that generates greater
value for our customers,” commented Julie Stegman,
Vice President of the Health LRP
Nursing Segment at
Wolters Kluwer. “NurseTim’s focus on faculty
preparation and nurse clinical judgement training aligns well with
our existing focus on ensuring nurses are clinically competent and
prepared to practice.”
“For over 15 years, NurseTim has been known as a leader in
innovation in nursing education and practice readiness. Through the
creation of strategies and tools that are accessible to faculty and
students, NurseTim is ushering the industry into a new era. We are
excited by Wolters Kluwer’s proven success with its Lippincott
solutions and positive impact on the profession. This track record
and our shared commitment to nursing program outcomes and student
success make it a good fit for the next phase of growth for
NurseTim,” commented Tim Bristol,
NurseTim, founded in 2008, is based in Minneapolis MN and
employs 48 professionals. Wolters Kluwer expects the investment to
deliver a return on invested capital (ROIC) above its weighted
average cost of capital (8%) within 3-5 years and expects the
transaction to have an immaterial impact on adjusted earnings.
About Wolters KluwerWolters Kluwer (EURONEXT:
WKL) is a global leader in professional information, software
solutions, and services for the healthcare; tax and accounting;
governance, risk and compliance; and legal and regulatory sectors.
We help our customers make critical decisions every day by
providing expert solutions that combine deep domain knowledge with
specialized technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion.
The group serves customers in over 180 countries, maintains
operations in over 40 countries, and employs approximately 20,000
people worldwide. The company is headquartered in Alphen aan den
Rijn, the Netherlands.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and
are included in the AEX and Euronext 100 indices. Wolters Kluwer
has a sponsored Level 1 American Depositary Receipt (ADR) program.
The ADRs are traded on the over-the-counter market in the U.S.
For more information, visit www.wolterskluwer.com, follow
us on LinkedIn, Twitter, Facebook, and YouTube.
|Gerbert van Genderen
|t + 31 172 641
||t +1 781 392
||t + 31 172 641
Forward-looking Statements and Other Important Legal
InformationThis report contains forward-looking
statements. These statements may be identified by words such as
“expect”, “should”, “could”, “shall” and similar expressions.
Wolters Kluwer cautions that such forward-looking statements are
qualified by certain risks and uncertainties that could cause
actual results and events to differ materially from what is
contemplated by the forward-looking statements. Factors which could
cause actual results to differ from these forward-looking
statements may include, without limitation: general economic
conditions; conditions in the markets in which Wolters Kluwer is
engaged; behavior of customers, suppliers, and competitors;
technological developments; the implementation and execution of new
ICT systems or outsourcing; and legal, tax, and regulatory rules
affecting Wolters Kluwer’s businesses, as well as risks related to
mergers, acquisitions, and divestments. In addition, financial
risks such as currency movements, interest rate fluctuations,
liquidity, and credit risks could influence future results. The
foregoing list of factors should not be construed as exhaustive.
Wolters Kluwer disclaims any intention or obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
Certain trademarks referenced are owned by Wolters Kluwer N.V.
and its subsidiaries and may be registered in various
- 2023.01.09 Wolters Kluwer acquires NurseTim
Grafico Azioni Wolters Kluwers NV (EU:WKL)
Da Feb 2023 a Mar 2023
Grafico Azioni Wolters Kluwers NV (EU:WKL)
Da Mar 2022 a Mar 2023